HCW Biologics Inc. Common Stock ($0.0001 par value per share) Capital on Demand™ Sales AgreementCapital on Demand Sales Agreement • August 19th, 2022 • HCW Biologics Inc. • Pharmaceutical preparations • New York
HCW Biologics Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with JonesTrading Institutional Services LLC (the “Agent”), as follows:
